CLOV

SEC source: 0001839066-26-000054 · wk-form4_1791411631.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,792,690

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.54 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001839066-26-000052 · wk-form4_1791241251.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,794,696

F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting of 6.25% of restricted stock units (the "RSUs") on October 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023, with a final vesting on January 3, 2027, subject to the continued service of the Reporting Person on such final vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

SEC source: 0001801170-26-000242 · wk-form4_1790971970.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,140,510

F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the quarterly vesting on October 1, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on January 1, 2023. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 to $4.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001801170-26-000244 · wk-form4_1790972112.xml · nonDerivative · entry 1

Miller Brian James · CIK 0002157846 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,481

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs") granted to the Reporting Person on September 30, 2026. The RSUs will vest in full on the first anniversary of September 30, 2026 subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

SEC source: 0001801170-26-000243 · wk-form4_1790972057.xml · nonDerivative · entry 1

Torricelli Robert G · CIK 0001700139 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 186,897

F1 · shares: Represents shares of Class A common stock of Clover Health Investments, Corp. (the "Company") underlying a time-based restricted stock unit award ("RSUs") granted to the Reporting Person on September 30, 2026. The RSUs will vest in full on the first anniversary of September 30, 2026 subject to the Reporting Person's continued service as a member of the Company's Board of Directors through such vesting date.

SEC source: 0001839066-26-000047 · wk-form4_1789762962.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,803,446

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.

SEC source: 0001801170-26-000223 · wk-form4_1789680572.xml · nonDerivative · entry 1

OLDAKOWSKI JOSEPH FRANK · CIK 0002128814 · VP OF FINANCE AND CONTROLLER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 275,897

F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units ("RSUs") originally granted to the Reporting Person on June 16, 2025. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on June 16, 2029, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

SEC source: 0001971702-26-000017 · wk-form4_1789590444.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust.

Disclosed balance after: 1,170,056

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 8, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.60 to $5.06, inclusive. The Reporting Person undertakes to provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.

SEC source: 0001999086-26-000031 · wk-form4_1789517478.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,607,371

F1 · shares: The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the final vesting of 6.25% of restricted stock units originally granted to the Reporting Person on September 15, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001839066-26-000045 · wk-form4_1789516081.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,805,367

F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the final 6.25% of restricted stock units (the "RSUs") on September 15, 2026. The RSUs were originally granted to the Reporting Person on September 16, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.70 to $4.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001801170-26-000218 · wk-form4_1789433557.xml · nonDerivative · entry 1

OLDAKOWSKI JOSEPH FRANK · CIK 0002128814 · VP OF FINANCE AND CONTROLLER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 279,067

SEC source: 0001801170-26-000207 · wk-form4_1787003898.xml · nonDerivative · entry 1

THORNTON JOSEPH CLAY · CIK 0002128794 · Interim CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,249,526

F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on August 16, 2026. The RSUs were originally granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.29 to $4.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001801170-26-000202 · wk-form4_1786652455.xml · nonDerivative · entry 1

THORNTON JOSEPH CLAY · CIK 0002128794 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,267,301

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of August 12, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of August 12, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on August 12, 2030.

SEC source: 0001999086-26-000023 · wk-form4_1786652630.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,614,217

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of August 12, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of August 12, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on August 12, 2030.

SEC source: 0001838733-26-000028 · wk-form4_1786401005.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,459,316

F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the final vesting on August 8, 2026 of 6.25% of restricted stock units originally granted to the Reporting Person on August 8, 2022. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.65, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001999086-26-000021 · wk-form4_1784584133.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,505,522

F1 · shares: The sales reported in this Form 4 were effected pursuant to a 10b5-1 plan adopted by the Reporting Person on March 13, 2026.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.46 to $4.59, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001839066-26-000039 · wk-form4_1784323597.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,814,640

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.35 to $4.63, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001801170-26-000179 · wk-form4_1784235556.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,547,114

F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units ("RSUs") originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001801170-26-000178 · wk-form4_1784235321.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,145,699

F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units ("RSUs") originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001801170-26-000176 · wk-form4_1784235002.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,819,479

F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on July 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.72, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001801170-26-000175 · wk-form4_1784234686.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,557,222

F1 · shares: The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001801170-26-000174 · wk-form4_1784234535.xml · nonDerivative · entry 1

THORNTON JOSEPH CLAY · CIK 0002128794 · Interim CFO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,212,954

F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on July 15, 2026. The RSUs were originally granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.67 to $4.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001839066-26-000033 · wk-form4_1783629938.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,832,598

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026.

SEC source: 0001839066-26-000031 · wk-form4_1783375051.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,834,982

F1 · kind: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units (the "RSUs") on July 3, 2026. The RSUs were originally granted to the Reporting Person on January 3, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

SEC source: 0001838733-26-000015 · wk-form4_1782945186.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,609,825

F1 · shares: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 6.25% of restricted stock units ("RSUs") originally granted to the Reporting Person on January 1, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

SEC source: 0001839066-26-000024 · wk-form4_1781779319.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,841,211

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.73 to $4.87, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Remarks:

SEC source: 0001801170-26-000161 · wk-form4_1781698407.xml · nonDerivative · entry 1

OLDAKOWSKI JOSEPH FRANK · CIK 0002128814 · VP OF FINANCE AND CONTROLLER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 299,067

F1 · kind: The sales reported on this Form 4 represent shares of Class A Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of 25% of restricted stock units ("RSUs") originally granted to the Reporting Person on June 16, 2025. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on June 16, 2029, subject to the continued service of the Reporting Person on each such vesting date. These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

SEC source: 0001839066-26-000022 · wk-form4_1781612073.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,843,571

F1 · kind: The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001801170-26-000151 · wk-form4_1781612213.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · Chief Legal Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 1,567,741

F1 · kind: The sales reported on this Form 4 represent shares of Common Stock required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units ("RSUs"). These sales are mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and do not represent discretionary trades by the Reporting Person.

F2 · price: The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.61 to $4.64, inclusive. The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.

SEC source: 0001839066-26-000017 · wk-form4_1781213277.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,849,921

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 12, 2026. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.79 to $5.15, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Remarks:

SEC source: 0001971702-26-000010 · wk-form4_1780008005.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: Plan reported

Ownership: Indirect · By Trust.

Disclosed balance after: 1,390,056

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2025. The price reported in Column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $3.92 to $4.04, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

F2 · ownership.nature: Shares held in trust for the benefit of the Reporting Person's family, of which the Reporting Person is a co-trustee.

SEC source: 0001801170-26-000131 · wk-form4_1779226357.xml · nonDerivative · entry 1

Edwards Carladenise Armbrister · CIK 0001937412 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 285,432

F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.41 to $3.43, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.

SEC source: 0001801170-26-000130 · wk-form4_1779135782.xml · nonDerivative · entry 1

THORNTON JOSEPH CLAY · CIK 0002128794 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,217,584

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on May 16, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on February 16, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on February 16, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001938197-26-000011 · wk-form4_1778723260.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Clover Care Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,040,222

SEC source: 0001801170-26-000123 · wk-form4_1778617015.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,923,301

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on May 8, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on August 8, 2022, and timely reported on a Form 4 filed on August 10, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with a final vesting date occurring on August 8, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-26-000090 · wk-form4_1776802747.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Clover Care Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,138,261

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations upon the vesting, on April 18, 2026, of 6.25% of the original number of time-based restricted stock units ("RSUs") granted to the Reporting Person on July 18, 2022, and timely reported on a Form 4 filed on July 19, 2022. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on July 18, 2026, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001938197-26-000008 · wk-form4_1776386227.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Clover Care Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,174,374

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001999086-26-000012 · wk-form4_1776385505.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,572,422

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001838733-26-000012 · wk-form4_1776370406.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,009,005

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001839066-26-000015 · wk-form4_1776370186.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,857,210

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001801170-26-000089 · wk-form4_1776370321.xml · nonDerivative · entry 1

THORNTON JOSEPH CLAY · CIK 0002128794 · Interim CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,234,526

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001971702-26-000007 · wk-form4_1776370018.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,169,914

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 15, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on October 15, 2024, and timely reported on a Form 4 filed on October 17, 2024. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on October 15, 2028, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001839066-26-000014 · wk-form4_1775593688.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,869,922

F1 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations due to the vesting on April 3, 2026, of 6.25% of the restricted stock units ("RSUs") granted to the Reporting Person on January 3, 2023, and originally reported on a Form 4 filed on January 5, 2023. The remaining RSUs will vest in equal quarterly installments, with the final vesting occurring on January 3, 2027, in each case subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001938197-26-000007 · wk-form4_1775249965.xml · nonDerivative · entry 1

Priest Brady Patrick · CIK 0001938197 · CEO of Clover Care Services

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,189,845

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030.

SEC source: 0001839066-26-000012 · wk-form4_1775248480.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,876,119

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030.

SEC source: 0001971702-26-000006 · wk-form4_1775247922.xml · nonDerivative · entry 1

Wai Conrad · CIK 0001971702 · CEO, Counterpart Health

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,193,377

F1 · shares: 1. Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030.

SEC source: 0001838733-26-000011 · wk-form4_1775248272.xml · nonDerivative · entry 2

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,069,770

F2 · shares: Represents shares of Class A Common Stock that were automatically withheld to cover tax obligations on April 1, 2026, due to the vesting of 6.25% of the original number of restricted stock units (RSUs) granted to the Reporting Person on January 1, 2023, and timely reported on a Form 4 filed on January 4, 2023. The remaining RSUs vest quarterly in equal installments of 6.25%, with the final vesting date occurring on January 1, 2027, subject to the continued service of the Reporting Person on each such vesting date.

SEC source: 0001838733-26-000011 · wk-form4_1775248272.xml · nonDerivative · entry 1

Toy Andrew · CIK 0001838733 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,379,328

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030.

SEC source: 0001999086-26-000011 · wk-form4_1775247653.xml · nonDerivative · entry 1

Soares Karen · CIK 0001999086 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,582,583

F1 · shares: Represents shares of Class A common stock underlying a time-based restricted stock unit award ("RSUs"). Twenty-five percent of the RSUs will vest on the first anniversary of April 1, 2026, and the remaining RSUs will vest in twelve equal quarterly installments beginning on the date that is three months after the first anniversary of April 1, 2026, in each case subject to the continued service of the Reporting Person on each such vesting date, so that such RSUs will be fully vested on April 1, 2030.

SEC source: 0001839066-26-000009 · wk-form4_1773871875.xml · nonDerivative · entry 1

Reynoso Jamie L. · CIK 0001839066 · CEO, Medicare Advantage

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 2,716,735

F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 13, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.87 to $1.96, inclusive. The Reporting Person undertakes to provide to the SEC staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Remarks: